Hesperetin regulates PI3K/Akt and mTOR pathways to exhibit its antiproliferative effect against colon cancer cells

Gowrikumar Saiprasad1, Palanivel Chitra1, Ramar Manikandan2

  • 1Department of Biochemistry, Cell Biology Laboratory, University of Madras, Chennai, India.

Insights

Hesperetin, a citrus flavonoid, effectively inhibits colon cancer cell growth by inducing apoptosis and autophagy. It regulates the Akt and mTOR signaling pathways, showing therapeutic potential against colon carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Hesperetin, a citrus flavonoid, is recognized for its anticancer properties, yet its precise mechanisms against colon cancer remain unclear.
  • Understanding hesperetin's molecular targets is crucial for developing effective colon cancer therapies.

Purpose of the Study:

  • To elucidate the anticancer mechanisms of hesperetin in colon cancer cells.
  • To investigate hesperetin's effects on cell proliferation, apoptosis, and autophagy.
  • To analyze the involvement of the PI3K/Akt/mTOR signaling pathway.

Main Methods:

  • HCT-15 colon cancer cells were treated with varying concentrations of hesperetin.
  • Immunoblotting was employed to assess protein expression and phosphorylation.
  • Scanning and transmission electron microscopy were used to examine cellular changes.

Main Results:

  • Hesperetin significantly reduced colon cancer cell proliferation and viability in a dose- and time-dependent manner.
  • Apoptosis was induced via a caspase-dependent pathway.
  • Hesperetin inhibited Akt phosphorylation and increased PTEN, suppressing the PI3K/Akt axis.
  • Autophagy was enhanced by hesperetin through mTOR dephosphorylation, upregulating Beclin-1 and LC3-II.
  • Hesperetin potentiated the effects of Akt and mTOR inhibitors.

Conclusions:

  • Hesperetin exhibits anticancer effects by inducing apoptosis and enhancing autophagy in colon cancer cells.
  • The therapeutic efficacy of hesperetin involves the regulation of the Akt and mTOR signaling pathways.
  • Hesperetin demonstrates significant potential as a therapeutic agent for colon carcinoma.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K